Skip to main content
Top
Published in: BMC Medical Genetics 1/2011

Open Access 01-12-2011 | Research article

Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study

Authors: Marieke Emonts, Mieke JMW Hazes, Jeanine J Houwing-Duistermaat, Christa E van der Gaast-de Jongh, Lisette de Vogel, Huub KH Han, Jacques MGW Wouters, Jon D Laman, Radboud JEM Dolhain

Published in: BMC Medical Genetics | Issue 1/2011

Login to get access

Abstract

Background

Various cytokines and inflammatory mediators are known to be involved in the pathogenesis of rheumatoid arthritis (RA). We hypothesized that polymorphisms in selected inflammatory response and tissue repair genes contribute to the susceptibility to and severity of RA.

Methods

Polymorphisms in TNFA, IL1B, IL4, IL6, IL8, IL10, PAI1, NOS2a, C1INH, PARP, TLR2 and TLR4 were genotyped in 376 Caucasian RA patients and 463 healthy Caucasian controls using single base extension. Genotype distributions in patients were compared with those in controls. In addition, the association of polymorphisms with the need for anti-TNF-α treatment as a marker of RA severity was assessed.

Results

The IL8 781 CC genotype was associated with early onset of disease. The TNFA -238 G/A polymorphism was differentially distributed between RA patients and controls, but only when not corrected for age and gender. None of the polymorphisms was associated with disease severity.

Conclusions

We here report an association between IL8 781 C/T polymorphism and age of onset of RA. Our findings indicate that there might be a role for variations in genes involved in the immune response and in tissue repair in RA pathogenesis. Nevertheless, additional larger genomic and functional studies are required to further define their role in RA.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Zwerina J, Redlich K, Schett G, Smolen JS: Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann N Y Acad Sci. 2005, 1051: 716-729. 10.1196/annals.1361.116.CrossRefPubMed Zwerina J, Redlich K, Schett G, Smolen JS: Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann N Y Acad Sci. 2005, 1051: 716-729. 10.1196/annals.1361.116.CrossRefPubMed
3.
go back to reference Heinzmann A, Ahlert I, Kurz T, Berner R, Deichmann KA: Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. 2004, 114: 671-676. 10.1016/j.jaci.2004.06.038.CrossRefPubMed Heinzmann A, Ahlert I, Kurz T, Berner R, Deichmann KA: Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. 2004, 114: 671-676. 10.1016/j.jaci.2004.06.038.CrossRefPubMed
4.
go back to reference Rodenburg RJ, van Den Hoogen FH, Barrera P, van Venrooij WJ, van De Putte LB: Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients. Ann Rheum Dis. 1999, 58: 648-652. 10.1136/ard.58.10.648.CrossRefPubMedPubMedCentral Rodenburg RJ, van Den Hoogen FH, Barrera P, van Venrooij WJ, van De Putte LB: Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients. Ann Rheum Dis. 1999, 58: 648-652. 10.1136/ard.58.10.648.CrossRefPubMedPubMedCentral
5.
go back to reference Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K: Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol. 1994, 56: 559-564.PubMed Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K: Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol. 1994, 56: 559-564.PubMed
6.
go back to reference Maini RN, Taylor PC, Szechinski J, Pavelka K, Broll J, Balint G, Emery P, Raemen F, Petersen J, Smolen J, et al: Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum. 2006, 54: 2817-2829. 10.1002/art.22033.CrossRefPubMed Maini RN, Taylor PC, Szechinski J, Pavelka K, Broll J, Balint G, Emery P, Raemen F, Petersen J, Smolen J, et al: Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum. 2006, 54: 2817-2829. 10.1002/art.22033.CrossRefPubMed
7.
go back to reference Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegard D, van den Berg WB: Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res. 1999, 1: 81-91. 10.1186/ar14.CrossRefPubMedPubMedCentral Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegard D, van den Berg WB: Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res. 1999, 1: 81-91. 10.1186/ar14.CrossRefPubMedPubMedCentral
8.
go back to reference Keystone E, Wherry J, Grint P: IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am. 1998, 24: 629-639. 10.1016/S0889-857X(05)70030-2.CrossRefPubMed Keystone E, Wherry J, Grint P: IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am. 1998, 24: 629-639. 10.1016/S0889-857X(05)70030-2.CrossRefPubMed
9.
go back to reference Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, Czipri M, Mikecz K, Zhang J: IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol. 2002, 169: 3345-3352.CrossRefPubMed Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, Czipri M, Mikecz K, Zhang J: IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol. 2002, 169: 3345-3352.CrossRefPubMed
10.
go back to reference Prots I, Skapenko A, Wendler J, Mattyasovszky S, Yone CL, Spriewald B, Burkhardt H, Rau R, Kalden JR, Lipsky PE, Schulze-Koops H: Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum. 2006, 54: 1491-1500. 10.1002/art.21832.CrossRefPubMed Prots I, Skapenko A, Wendler J, Mattyasovszky S, Yone CL, Spriewald B, Burkhardt H, Rau R, Kalden JR, Lipsky PE, Schulze-Koops H: Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum. 2006, 54: 1491-1500. 10.1002/art.21832.CrossRefPubMed
11.
go back to reference Kjoller L, Kanse SM, Kirkegaard T, Rodenburg KW, Ronne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA: Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp Cell Res. 1997, 232: 420-429. 10.1006/excr.1997.3540.CrossRefPubMed Kjoller L, Kanse SM, Kirkegaard T, Rodenburg KW, Ronne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA: Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp Cell Res. 1997, 232: 420-429. 10.1006/excr.1997.3540.CrossRefPubMed
12.
go back to reference Stefansson S, Lawrence DA: The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. 1996, 383: 441-443. 10.1038/383441a0.CrossRefPubMed Stefansson S, Lawrence DA: The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. 1996, 383: 441-443. 10.1038/383441a0.CrossRefPubMed
13.
go back to reference Li J, Guo Y, Holmdahl R, Ny T: Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. Arthritis Rheum. 2005, 52: 2541-2548. 10.1002/art.21229.CrossRefPubMed Li J, Guo Y, Holmdahl R, Ny T: Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. Arthritis Rheum. 2005, 52: 2541-2548. 10.1002/art.21229.CrossRefPubMed
14.
go back to reference Criswell LA, Gregersen PK: Current understanding of the genetic aetiology of rheumatoid arthritis and likely future developments. Rheumatology (Oxford). 2005, 44 (Suppl 4): iv9-iv13. 10.1093/rheumatology/kei054.CrossRef Criswell LA, Gregersen PK: Current understanding of the genetic aetiology of rheumatoid arthritis and likely future developments. Rheumatology (Oxford). 2005, 44 (Suppl 4): iv9-iv13. 10.1093/rheumatology/kei054.CrossRef
15.
go back to reference Gibert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D: Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum Immunol. 2003, 64: 930-935. 10.1016/S0198-8859(03)00186-1.CrossRefPubMed Gibert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D: Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum Immunol. 2003, 64: 930-935. 10.1016/S0198-8859(03)00186-1.CrossRefPubMed
16.
go back to reference Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, Okamoto K, Furugaki K, Matsumoto T, Mano S, Ando S, et al: Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet. 2005, 14: 2305-2321. 10.1093/hmg/ddi234.CrossRefPubMed Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, Okamoto K, Furugaki K, Matsumoto T, Mano S, Ando S, et al: Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet. 2005, 14: 2305-2321. 10.1093/hmg/ddi234.CrossRefPubMed
17.
go back to reference Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Gibbons L, Plant D, Wilson AG, Marinou I, et al: Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet. 2008, 17: 2274-2279. 10.1093/hmg/ddn128.CrossRefPubMedPubMedCentral Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Gibbons L, Plant D, Wilson AG, Marinou I, et al: Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet. 2008, 17: 2274-2279. 10.1093/hmg/ddn128.CrossRefPubMedPubMedCentral
18.
go back to reference Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Plant D, Gibbons LJ, Wilson AG, Bax DE, et al: Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat Genet. 2008, 40: 1156-1159. 10.1038/ng.218.CrossRefPubMedPubMedCentral Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Plant D, Gibbons LJ, Wilson AG, Bax DE, et al: Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat Genet. 2008, 40: 1156-1159. 10.1038/ng.218.CrossRefPubMedPubMedCentral
19.
go back to reference Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987, 30: 1205-1213. 10.1002/art.1780301102.CrossRefPubMed Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987, 30: 1205-1213. 10.1002/art.1780301102.CrossRefPubMed
20.
go back to reference Hinks A, Worthington J, Thomson W: The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology (Oxford). 2006, 45: 365-368. 10.1093/rheumatology/kel005.CrossRef Hinks A, Worthington J, Thomson W: The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology (Oxford). 2006, 45: 365-368. 10.1093/rheumatology/kel005.CrossRef
21.
go back to reference Orozco G, Hinks A, Eyre S, Ke X, Gibbons LJ, Bowes J, Flynn E, Martin P, Wilson AG, Bax DE, et al: Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum Mol Genet. 2009, 18: 2693-2699. 10.1093/hmg/ddp193.CrossRefPubMedPubMedCentral Orozco G, Hinks A, Eyre S, Ke X, Gibbons LJ, Bowes J, Flynn E, Martin P, Wilson AG, Bax DE, et al: Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum Mol Genet. 2009, 18: 2693-2699. 10.1093/hmg/ddp193.CrossRefPubMedPubMedCentral
22.
go back to reference Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FA, Zhernakova A, Hinks A, et al: Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010, 42: 508-514. 10.1038/ng.582.CrossRefPubMedPubMedCentral Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FA, Zhernakova A, Hinks A, et al: Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010, 42: 508-514. 10.1038/ng.582.CrossRefPubMedPubMedCentral
23.
go back to reference Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J, Donn R, Symmons D, Hider S, Bruce IN, et al: Rheumatoid arthritis association at 6q23. Nat Genet. 2007, 39: 1431-1433. 10.1038/ng.2007.32.CrossRefPubMedPubMedCentral Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J, Donn R, Symmons D, Hider S, Bruce IN, et al: Rheumatoid arthritis association at 6q23. Nat Genet. 2007, 39: 1431-1433. 10.1038/ng.2007.32.CrossRefPubMedPubMedCentral
24.
go back to reference Orozco G, Barton A: Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol. 2010, 6: 61-75. 10.1586/eci.09.72.CrossRefPubMed Orozco G, Barton A: Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol. 2010, 6: 61-75. 10.1586/eci.09.72.CrossRefPubMed
25.
go back to reference Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, Tanaka Y, Otsuka T, Harada M: Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun. 2002, 3: 107-109. 10.1038/sj.gene.6363830.CrossRefPubMed Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, Tanaka Y, Otsuka T, Harada M: Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun. 2002, 3: 107-109. 10.1038/sj.gene.6363830.CrossRefPubMed
26.
go back to reference Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998, 102: 1369-1376. 10.1172/JCI2629.CrossRefPubMedPubMedCentral Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998, 102: 1369-1376. 10.1172/JCI2629.CrossRefPubMedPubMedCentral
27.
go back to reference Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM: The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993, 268: 10739-10745.PubMed Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM: The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993, 268: 10739-10745.PubMed
28.
go back to reference Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ: The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res. 2004, 64: 6344-6348. 10.1158/0008-5472.CAN-04-0338.CrossRefPubMed Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ: The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res. 2004, 64: 6344-6348. 10.1158/0008-5472.CAN-04-0338.CrossRefPubMed
29.
go back to reference Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997, 24: 1-8. 10.1111/j.1365-2370.1997.tb00001.x.CrossRefPubMed Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997, 24: 1-8. 10.1111/j.1365-2370.1997.tb00001.x.CrossRefPubMed
30.
go back to reference Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, et al: Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 2006, 15: 519-529. 10.1093/hmg/ddi469.CrossRefPubMed Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, et al: Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 2006, 15: 519-529. 10.1093/hmg/ddi469.CrossRefPubMed
31.
go back to reference Wen AQ, Wang J, Feng K, Zhu PF, Wang ZG, Jiang JX: Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock. 2006, 26: 25-30. 10.1097/01.shk.0000223125.56888.c7.CrossRefPubMed Wen AQ, Wang J, Feng K, Zhu PF, Wang ZG, Jiang JX: Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock. 2006, 26: 25-30. 10.1097/01.shk.0000223125.56888.c7.CrossRefPubMed
32.
go back to reference Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M: 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet. 1999, 354: 556-560. 10.1016/S0140-6736(99)02220-5.CrossRefPubMed Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M: 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet. 1999, 354: 556-560. 10.1016/S0140-6736(99)02220-5.CrossRefPubMed
33.
go back to reference Correa PA, Gomez LM, Cadena J, Anaya JM: Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol. 2005, 32: 219-224.PubMed Correa PA, Gomez LM, Cadena J, Anaya JM: Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol. 2005, 32: 219-224.PubMed
34.
go back to reference Hull J, Ackerman H, Isles K, Usen S, Pinder M, Thomson A, Kwiatkowski D: Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet. 2001, 69: 413-419. 10.1086/321291.CrossRefPubMedPubMedCentral Hull J, Ackerman H, Isles K, Usen S, Pinder M, Thomson A, Kwiatkowski D: Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet. 2001, 69: 413-419. 10.1086/321291.CrossRefPubMedPubMedCentral
35.
go back to reference Rodriguez-Carreon AA, Zuniga J, Hernandez-Pacheco G, Rodriguez-Perez JM, Perez-Hernandez N, Montes de Oca JV, Cardiel MH, Granados J, Vargas-Alarcon G: Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun. 2005, 24: 63-68. 10.1016/j.jaut.2004.11.002.CrossRefPubMed Rodriguez-Carreon AA, Zuniga J, Hernandez-Pacheco G, Rodriguez-Perez JM, Perez-Hernandez N, Montes de Oca JV, Cardiel MH, Granados J, Vargas-Alarcon G: Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun. 2005, 24: 63-68. 10.1016/j.jaut.2004.11.002.CrossRefPubMed
36.
go back to reference van de Geijn FE, Roos A, de Man YA, Laman JD, de Groot CJ, Daha MR, Hazes JM, Dolhain RJ: Mannose-binding lectin levels during pregnancy: a longitudinal study. Hum Reprod. 2007, 22: 362-371. 10.1093/humrep/del392.CrossRefPubMed van de Geijn FE, Roos A, de Man YA, Laman JD, de Groot CJ, Daha MR, Hazes JM, Dolhain RJ: Mannose-binding lectin levels during pregnancy: a longitudinal study. Hum Reprod. 2007, 22: 362-371. 10.1093/humrep/del392.CrossRefPubMed
37.
go back to reference Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL: A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet. 2004, 68: 165-177. 10.1046/j.1529-8817.2003.00085.x.CrossRefPubMed Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL: A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet. 2004, 68: 165-177. 10.1046/j.1529-8817.2003.00085.x.CrossRefPubMed
38.
go back to reference Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002, 70: 425-434. 10.1086/338688.CrossRefPubMed Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002, 70: 425-434. 10.1086/338688.CrossRefPubMed
40.
go back to reference Klimiuk PA, Sierakowski S, Latosiewicz R, Skowronski J, Cylwik JP, Cylwik B, Chwiecko J: Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis. J Rheumatol. 2005, 32: 1666-1672.PubMed Klimiuk PA, Sierakowski S, Latosiewicz R, Skowronski J, Cylwik JP, Cylwik B, Chwiecko J: Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis. J Rheumatol. 2005, 32: 1666-1672.PubMed
41.
go back to reference Lo SF, Huang CM, Lin HC, Chen WC, Tsai CH, Tsai FJ: Cytokine (IL-6) and chemokine (IL-8) gene polymorphisms among rheumatoid arthritis patients in Taiwan. Clin Exp Rheumatol. 2008, 26: 632-637.PubMed Lo SF, Huang CM, Lin HC, Chen WC, Tsai CH, Tsai FJ: Cytokine (IL-6) and chemokine (IL-8) gene polymorphisms among rheumatoid arthritis patients in Taiwan. Clin Exp Rheumatol. 2008, 26: 632-637.PubMed
42.
go back to reference Khanna D, Wu H, Park G, Gersuk V, Gold RH, Nepom GT, Wong WK, Sharp JT, Reed EF, Paulus HE, Tsao BP: Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum. 2006, 54: 1105-1116. 10.1002/art.21750.CrossRefPubMed Khanna D, Wu H, Park G, Gersuk V, Gold RH, Nepom GT, Wong WK, Sharp JT, Reed EF, Paulus HE, Tsao BP: Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum. 2006, 54: 1105-1116. 10.1002/art.21750.CrossRefPubMed
43.
go back to reference Balog A, Klausz G, Gal J, Molnar T, Nagy F, Ocsovszky I, Gyulai Z, Mandi Y: Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis. Pathobiology. 2004, 71: 274-280. 10.1159/000080062.CrossRefPubMed Balog A, Klausz G, Gal J, Molnar T, Nagy F, Ocsovszky I, Gyulai Z, Mandi Y: Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis. Pathobiology. 2004, 71: 274-280. 10.1159/000080062.CrossRefPubMed
44.
go back to reference Seitz M, Wirthmuller U, Moller B, Villiger PM: The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford). 2006 Seitz M, Wirthmuller U, Moller B, Villiger PM: The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford). 2006
45.
go back to reference Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D: Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis. Arthritis Rheum. 2003, 48: 1849-1852. 10.1002/art.11168.CrossRefPubMed Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D: Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis. Arthritis Rheum. 2003, 48: 1849-1852. 10.1002/art.11168.CrossRefPubMed
46.
go back to reference Bayley JP, Ottenhoff TH, Verweij CL: Is there a future for TNF promoter polymorphisms?. Genes Immun. 2004, 5: 315-329. 10.1038/sj.gene.6364055.CrossRefPubMed Bayley JP, Ottenhoff TH, Verweij CL: Is there a future for TNF promoter polymorphisms?. Genes Immun. 2004, 5: 315-329. 10.1038/sj.gene.6364055.CrossRefPubMed
47.
go back to reference Lindberg J, Af Klint E, Ulfgren AK, Stark A, Andersson T, Nilsson P, Klareskog L, Lundeberg J: Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology. Arthritis Res Ther. 2006, 8: R47-10.1186/ar1903.CrossRefPubMedPubMedCentral Lindberg J, Af Klint E, Ulfgren AK, Stark A, Andersson T, Nilsson P, Klareskog L, Lundeberg J: Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology. Arthritis Res Ther. 2006, 8: R47-10.1186/ar1903.CrossRefPubMedPubMedCentral
48.
go back to reference Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG: Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun. 2003, 4: 117-121. 10.1038/sj.gene.6363931.CrossRefPubMed Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG: Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun. 2003, 4: 117-121. 10.1038/sj.gene.6363931.CrossRefPubMed
49.
go back to reference Riyazi N, Kurreeman FA, Huizinga TW, Dekker FW, Stoeken-Rijsbergen G, Kloppenburg M: The role of interleukin 10 promoter polymorphisms in the susceptibility of distal interphalangeal osteoarthritis. J Rheumatol. 2005, 32: 1571-1575.PubMed Riyazi N, Kurreeman FA, Huizinga TW, Dekker FW, Stoeken-Rijsbergen G, Kloppenburg M: The role of interleukin 10 promoter polymorphisms in the susceptibility of distal interphalangeal osteoarthritis. J Rheumatol. 2005, 32: 1571-1575.PubMed
50.
go back to reference Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A: Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol. 2008, 27: 1243-1248. 10.1007/s10067-008-0893-1.CrossRefPubMed Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A: Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol. 2008, 27: 1243-1248. 10.1007/s10067-008-0893-1.CrossRefPubMed
51.
go back to reference Schluter B, Raufhake C, Erren M, Schotte H, Kipp F, Rust S, Van AH, Assmann G, Berendes E: Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med. 2002, 30: 32-37. 10.1097/00003246-200201000-00005.CrossRefPubMed Schluter B, Raufhake C, Erren M, Schotte H, Kipp F, Rust S, Van AH, Assmann G, Berendes E: Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med. 2002, 30: 32-37. 10.1097/00003246-200201000-00005.CrossRefPubMed
52.
go back to reference Terry CF, Loukaci V, Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000, 275: 18138-18144. 10.1074/jbc.M000379200.CrossRefPubMed Terry CF, Loukaci V, Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000, 275: 18138-18144. 10.1074/jbc.M000379200.CrossRefPubMed
53.
go back to reference Hegedus CM, Skibola CF, Bracci P, Holly EA, Smith MT: Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 - 174G > C polymorphism. Proteomics. 2007, 7: 548-557. 10.1002/pmic.200600366.CrossRefPubMed Hegedus CM, Skibola CF, Bracci P, Holly EA, Smith MT: Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 - 174G > C polymorphism. Proteomics. 2007, 7: 548-557. 10.1002/pmic.200600366.CrossRefPubMed
54.
go back to reference Smeets TJ, Barg EC, Kraan MC, Smith MD, Breedveld FC, Tak PP: Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis. 2003, 62: 635-638. 10.1136/ard.62.7.635.CrossRefPubMedPubMedCentral Smeets TJ, Barg EC, Kraan MC, Smith MD, Breedveld FC, Tak PP: Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis. 2003, 62: 635-638. 10.1136/ard.62.7.635.CrossRefPubMedPubMedCentral
55.
go back to reference Kuuliala K, Orpana A, Leirisalo-Repo M, Kautiainen H, Hurme M, Hannonen P, Korpela M, Mottonen T, Paimela L, Puolakka K, et al: Polymorphism at position +896 of the toll-like receptor 4 gene interferes with rapid response to treatment in rheumatoid arthritis. Ann Rheum Dis. 2006, 65: 1241-1243. 10.1136/ard.2006.055137.CrossRefPubMedPubMedCentral Kuuliala K, Orpana A, Leirisalo-Repo M, Kautiainen H, Hurme M, Hannonen P, Korpela M, Mottonen T, Paimela L, Puolakka K, et al: Polymorphism at position +896 of the toll-like receptor 4 gene interferes with rapid response to treatment in rheumatoid arthritis. Ann Rheum Dis. 2006, 65: 1241-1243. 10.1136/ard.2006.055137.CrossRefPubMedPubMedCentral
Metadata
Title
Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study
Authors
Marieke Emonts
Mieke JMW Hazes
Jeanine J Houwing-Duistermaat
Christa E van der Gaast-de Jongh
Lisette de Vogel
Huub KH Han
Jacques MGW Wouters
Jon D Laman
Radboud JEM Dolhain
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2011
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-12-36

Other articles of this Issue 1/2011

BMC Medical Genetics 1/2011 Go to the issue